Biggest News Aggregation in the World
📰 Resented News

Page 9 - Resented News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Resented. Real-time updates on events, politics, business and more.

Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing

Biodesix, Inc. , a leading data-driven diagnostic solutions company with a focus in lung disease, presented original data in four separate poster presentations at the ISPOR conference, providing... | May 25, 2023
Scott Hutton International Society For Outcomes Research Biodesix Inc International Society Blood Based Integrated Classifier Test

AUGA group, AB and its subsidiaries presented to the public and investors the principles of a new business model that will enable scaling of technology and sustainable food supply

AUGA group, AB presented the key principles of the new business model of the Company and its subsidiaries along with the steps for its implementation, as approved by the Company’s Board. The... | May 25, 2023
Company Board Auga Group Ab Stock Exchange Press Release He Aug1l Lt0000127466

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

After four years of follow-up, KEYTRUDA plus LENVIMA reduced the risk of death by 21% versus sunitinib in the pivotal Phase 3 CLEAR /KEYNOTE-581 trial Final results will be presented at ASCO 2023... | May 25, 2023
New Zealand United States Thomas Hutson Corina Dutcus Gregory Lubiniecki Urologic Cancer Research

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Genmab A/S: Genmab Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Congress

Oral presentations will highlight epcoritamab-bysp in combination with rituximab-lenalidomide (R2) in high-risk follicular lymphoma Poster presentations will highlight epcoritamab in lymphoma
United States New Jersey David Freundel Judith Klimovsky Andrew Carlsen Gewinn Nur

Adaptimmune Therapeutics PLC: Adaptimmune Announces 70% of People with Advanced Synovial Sarcoma Who Respond to Afami-cel are Alive Two Years Post-Treatment; Data from Cohort 1 of SPEARHEAD-1 to be Presented at ASCO

Approximately 39% of patients had clinical responses after a single dose of afami-cel in Cohort 1 of the pivotal SPEARHEAD-1 trial and the median duration of response was ~12 months (CTOS 2022)Median
Gewinn Nur Dana Lynch Dennis Williams Julip Miller John Charlson College Of Wisconsin

4DMT to Present Interim Data from 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis Lung Disease at the European Cystic Fibrosis Society (ECFS) 46th Annual Meeting

Interim data to be presented in an oral presentation by Dr. Jennifer L. Taylor-Cousar, MD, MSCS at the 2023 ECFS Annual Meeting in Vienna, Austria on Thursday, June 8, 2023 at 5:00 p.m. CET Company to... | May 24, 2023
United States Jenniferl Taylor Cousar Julian Pei Katherine Smith Exchange Commission Corporate Communications

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science